Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Additionally, lead time reductions of 1520% were observed in factories with digital twins ( [11] )
A pilot study to assess the safety, tolerability, and tumor responses with lenvatinib plus pembrolizumab in patients with advanced pancreatic ductal adenocarcinoma in second-line or later of treatment
"That's kind of what sparked our interest" in tracking the calls
Let our healthcare experts guide you to make the best decisions for your unique needs and take the next step towards a healthier, happier you
US$ 24.10
US$ 20.05
US$ 20.03
US$ 28.12
